Jinyu Bio-Technology Co Ltd (600201) - Total Assets
Based on the latest financial reports, Jinyu Bio-Technology Co Ltd (600201) holds total assets worth CN¥6.62 Billion CNY (≈ $968.24 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jinyu Bio-Technology Co Ltd - Total Assets Trend (1995–2025)
This chart illustrates how Jinyu Bio-Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 600201 market cap for the company's overall valuation and market capitalisation.
Jinyu Bio-Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Jinyu Bio-Technology Co Ltd's total assets of CN¥6.62 Billion consist of 35.5% current assets and 64.6% non-current assets. Review total liabilities of Jinyu Bio-Technology Co Ltd to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.1% |
| Accounts Receivable | CN¥591.09 Million | 8.9% |
| Inventory | CN¥269.13 Million | 4.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥688.46 Million | 10.4% |
| Goodwill | CN¥8.20 Million | 0.1% |
Asset Composition Trend (1995–2025)
This chart illustrates how Jinyu Bio-Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 600201 live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jinyu Bio-Technology Co Ltd's current assets represent 35.5% of total assets in 2025, a decrease from 60.4% in 1995.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2025, up from 0.5% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 3.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 10.4% of total assets.
Jinyu Bio-Technology Co Ltd Competitors by Total Assets
Key competitors of Jinyu Bio-Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
USA | $2.19 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
USA | $511.25 Million |
|
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
|
USA | $452.70 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
NANOBIOTIX S.A. SP.ADR
F:5NRA
|
Germany | €67.76 Million |
|
Savara Inc
NASDAQ:SVRA
|
USA | $192.14 Million |
Jinyu Bio-Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.21 | 2.79 | 4.86 |
| Quick Ratio | 3.82 | 2.40 | 4.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.15 Billion | CN¥1.35 Billion | CN¥2.50 Billion |
Jinyu Bio-Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Jinyu Bio-Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.38 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -2.3% |
| Total Assets | CN¥6.61 Billion |
| Market Capitalization | $1.89 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Jinyu Bio-Technology Co Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Jinyu Bio-Technology Co Ltd's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Jinyu Bio-Technology Co Ltd (1995–2025)
The table below shows the annual total assets of Jinyu Bio-Technology Co Ltd from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.61 Billion ≈ $967.48 Million |
-2.26% |
| 2024-12-31 | CN¥6.76 Billion ≈ $989.88 Million |
-1.57% |
| 2023-12-31 | CN¥6.87 Billion ≈ $1.01 Billion |
+7.56% |
| 2022-12-31 | CN¥6.39 Billion ≈ $934.96 Million |
-3.25% |
| 2021-12-31 | CN¥6.60 Billion ≈ $966.36 Million |
+5.19% |
| 2020-12-31 | CN¥6.28 Billion ≈ $918.71 Million |
+12.40% |
| 2019-12-31 | CN¥5.59 Billion ≈ $817.39 Million |
-11.52% |
| 2018-12-31 | CN¥6.31 Billion ≈ $923.82 Million |
+11.08% |
| 2017-12-31 | CN¥5.68 Billion ≈ $831.69 Million |
+30.73% |
| 2016-12-31 | CN¥4.35 Billion ≈ $636.21 Million |
+70.48% |
| 2015-12-31 | CN¥2.55 Billion ≈ $373.18 Million |
+21.56% |
| 2014-12-31 | CN¥2.10 Billion ≈ $307.00 Million |
+22.57% |
| 2013-12-31 | CN¥1.71 Billion ≈ $250.47 Million |
-9.09% |
| 2012-12-31 | CN¥1.88 Billion ≈ $275.52 Million |
+9.13% |
| 2011-12-31 | CN¥1.73 Billion ≈ $252.47 Million |
+8.59% |
| 2010-12-31 | CN¥1.59 Billion ≈ $232.49 Million |
+13.55% |
| 2009-12-31 | CN¥1.40 Billion ≈ $204.74 Million |
+12.60% |
| 2008-12-31 | CN¥1.24 Billion ≈ $181.82 Million |
-4.07% |
| 2007-12-31 | CN¥1.30 Billion ≈ $189.53 Million |
+37.78% |
| 2006-12-31 | CN¥940.08 Million ≈ $137.56 Million |
-9.97% |
| 2005-12-31 | CN¥1.04 Billion ≈ $152.80 Million |
-0.93% |
| 2004-12-31 | CN¥1.05 Billion ≈ $154.23 Million |
+9.97% |
| 2003-12-31 | CN¥958.43 Million ≈ $140.25 Million |
+17.86% |
| 2002-12-31 | CN¥813.22 Million ≈ $119.00 Million |
+6.76% |
| 2001-12-31 | CN¥761.73 Million ≈ $111.46 Million |
+33.38% |
| 2000-12-31 | CN¥571.09 Million ≈ $83.57 Million |
+19.79% |
| 1999-12-31 | CN¥476.73 Million ≈ $69.76 Million |
+8.56% |
| 1998-12-31 | CN¥439.12 Million ≈ $64.26 Million |
+115.40% |
| 1997-12-31 | CN¥203.87 Million ≈ $29.83 Million |
-2.74% |
| 1996-12-31 | CN¥209.62 Million ≈ $30.67 Million |
-1.63% |
| 1995-12-31 | CN¥213.09 Million ≈ $31.18 Million |
-- |
About Jinyu Bio-Technology Co Ltd
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary biological products in China and internationally. The company's products focus on preventing porcine mycoplasmal pneumonia, pseudorabies, highly pathogenic avian influenza, brucellosis, and other Class I, II, and III animal diseases. It also provides pig vaccines, swine foot-and-mouth diseas… Read more